Hamilton Thomas Edward bought LRMR
February 27, 2026 · Form 4 insider transaction
Hamilton Thomas Edward bought 100,000 shares of Larimar Therapeutics, Inc. at $5.00 per share, a transaction worth $500.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
$5.00
Total value
$500.0K
InsiderHamilton Thomas Edward
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 27, 2026
Filing dateMarch 2, 2026
Shares owned after664,798
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026.